Bio-Synthesis Introduces "BNA-NC" -- A Third Generation Multi-Functional Bridged Nucleic Acid
11/15/2012 7:48:54 AM
LEWISVILLE, Texas, Nov. 14, 2012 (GLOBE NEWSWIRE) -- Bio-Synthesis, Inc., a leading biotech supplier of chemical biology reagents, is proud to announce that it has acquired a license from BNA Inc. of Osaka, Japan for the manufacturing and distribution of BNA-NC, a third generation of BNA oligonucleotides. This agreement is valid worldwide with the exception of Japan and is meant for research use only at this time (Patents JP: 4731324(2011.4.28), USP: 7427672(2008.9.23), EP: 1551905(2012.4.25)).
comments powered by